Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C.
about
Chemophototherapy: An Emerging Treatment Option for Solid TumorsPancreatic cancer-associated Cathepsin E as a drug activator.Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model.Enhancement of meta-tetrahydroxyphenylchlorin-sensitized photodynamic treatment on human tumor xenografts using a water-soluble vitamin E analogue, Trolox.Potentiation of photodynamic therapy with hypericin by mitomycin C in the radiation-induced fibrosarcoma-1 mouse tumor model.Enhancing the antitumoral effect of hypericin-mediated photodynamic therapy by hyperthermia.Photosensitizing effects of m-tetrahydroxyphenylchlorin on human tumor xenografts: correlation with sensitizer uptake, tumor doubling time and tumor histology.Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer in vivoImplicit and explicit dosimetry in photodynamic therapy: a New paradigm.Photodynamic therapy of cancer: an updateVascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapyIntraperitoneal photodynamic therapy of the rat CC531 adenocarcinoma.Enhancement of photodynamic therapy by mitomycin C: a preclinical and clinical study.Prospects for bioreductive drug development.Foscan uptake and tissue distribution in relation to photodynamic efficacy.Electron spin resonance evidence of the generation of superoxide anion, hydroxyl radical and singlet oxygen during the photohemolysis of human erythrocytes with bacteriochlorin a.Temoporfin (Foscan®, 5,10,15,20-tetra(m-hydroxyphenyl)chlorin)--a second-generation photosensitizer.Enhancing photodynamyc therapy efficacy by combination therapy: dated, current and oncoming strategiesInterstitial photodynamic therapy with the second-generation photosensitizer bacteriochlorin a in a rat model for liver metastases.Interaction between photodynamic therapy and BCG immunotherapy responsible for the reduced recurrence of treated mouse tumors.
P2860
Q28468315-905B7D87-3CDE-439B-9D68-B16BF5905BDBQ30539289-85771E71-E5BB-4438-9848-50F666E85853Q30816583-B3CF095A-17ED-4FF6-83A4-6247DD6EE406Q30958989-05807234-B42A-41C6-83F3-AE2542CB55CBQ31011104-B01920BD-04A1-4DFE-AD9B-9992BBFC0A7CQ31108907-544B8962-33BC-48E5-A3E0-7D7EC4F96580Q32061146-8210BCDD-1570-4C1D-BBFB-32DA15532898Q33218362-4276AD75-9E03-465C-9F26-57E23D43EEEFQ33409922-72102888-3F2B-4749-8DF5-7B2FE29D82A5Q33677933-4F5B843B-27AB-42B1-A2B2-B87810FD267EQ35532394-F02327E1-2DD7-4AE2-B48B-A0908A50A8F7Q36134960-5006CB51-5204-4961-A7EE-469111009F29Q36135116-C4BB5455-C818-48CD-9723-D1871B5442F1Q36138687-BE47B03B-CAC0-4A2B-B563-7646268D63D5Q36181210-09160AB2-48F0-47C4-9F1E-BD0A70E70FEBQ36648672-B4C68747-0C7C-4851-BB49-8E934AC3B3A7Q36886964-ADE28F8C-ACFB-433E-872E-B528513EB06FQ37919156-EF163F4A-3D7A-49B5-A980-B131B0A71876Q38161363-B354F332-0691-439C-98D7-C2428A304E70Q42061393-C5AB1AEB-21DE-4E74-8429-FD59B718237CQ43594697-01C05A65-91CC-410A-AD18-755756BCEBF7
P2860
Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Mechanisms for optimising phot ...... combination with mitomycin C.
@ast
Mechanisms for optimising phot ...... combination with mitomycin C.
@en
type
label
Mechanisms for optimising phot ...... combination with mitomycin C.
@ast
Mechanisms for optimising phot ...... combination with mitomycin C.
@en
prefLabel
Mechanisms for optimising phot ...... combination with mitomycin C.
@ast
Mechanisms for optimising phot ...... combination with mitomycin C.
@en
P2093
P2860
P356
P1476
Mechanisms for optimising phot ...... combination with mitomycin C.
@en
P2093
Oppelaar H
Oussoren YG
Schuitmaker JJ
Stewart FA
van Geel IP
P2860
P2888
P304
P356
10.1038/BJC.1995.336
P407
P577
1995-08-01T00:00:00Z